BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, July 13, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Regulatory actions for Feb. 3, 2023

Feb. 3, 2023
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amgen, Astrazeneca, Calliditas, GSK, Pfizer, Pharmather, Pliant, Y-mabs.
Read More

Other news to note for Feb. 3, 2023

Feb. 3, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Karuna, Goldfinch, Healion, Immunorizon, Magenta, Pherin, Purple, Tonix, Vistagen.
Read More

In the clinic for Feb. 3, 2023

Feb. 3, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agomab, Amylyx, Anaveon, Anavex, Arrowhead, Artelo, Aulos, Biophytis, Clearside, Exscientia, First Wave, Inovio, Moonlake, Nrx, Oligomerix.
Read More

Financings for Feb. 3, 2023

Feb. 3, 2023
Biopharmas raising money in public or private financings, including: Avalo, Cellectis, Ensysce, Kiora, Paxmedica, Provention, Roivant, Structure, Tenax.
Read More

Appointments and advancements for Feb. 3, 2023

Feb. 3, 2023
New hires and promotions in the biopharma industry, including: Ambrx, Engene, Invivyd, Treadwell, Vaxxinity.
Read More

Regulatory actions for Feb. 2, 2023

Feb. 2, 2023
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aspivix, Qvin, Reflexion Medical.
Read More

Other news to note for Feb. 2, 2023

Feb. 2, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Babson Diagnostics, Digital Diagnostics, Dynatronics, Invacare, Nanostring Technologies, Sonire Therapeutics, Tamer Healthcare, Tyber Medical.
Read More

In the clinic for Feb. 2, 2023

Feb. 2, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Immunexpress.
Read More

Appointments and advancements for Feb. 2, 2023

Feb. 2, 2023
New hires and promotions in the med-tech industry, including: Accuray, Femselect, Illumina.
Read More

Regulatory actions for Feb. 2, 2023

Feb. 2, 2023
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Agile, Artiva, Beactica, Edesa, Ellipses, Flag, Genoscience, Greenlight, Mesoblast, ONL, Roche, Taysha, Xortx.
Read More
Previous 1 2 … 890 891 892 893 894 895 896 897 898 … 1820 1821 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 10, 2026.
  • Wainua autoinjector

    Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

    BioWorld
    News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
  • Silhouette with keyhole

    FENS 2026: Next-gen biologics take on brain disease

    BioWorld
    Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
  • Art concept for medical research

    FENS 2026: Shedding light on the sheddome

    BioWorld
    At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing